Pharmacodynamic Analyses of Metabolic Agents Following Brain Radiation

NCT05720624 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Funding issues

Conditions

Malignant Central Nervous System Neoplasm

Interventions

DRUG: Anhydrous Enol-oxaloacetate
OTHER: Best Practice
PROCEDURE: Biospecimen Collection
PROCEDURE: Magnetic Resonance Spectroscopic Imaging
OTHER: Questionnaire Administration

Sponsor

Mayo Clinic